Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals. 

Humana maintained its 2026 adjusted profit outlook of at least $9 per share, which some analysts called a “disappointment” amid high expectations for insurers.

The four newly linked states — Illinois, Kansas, Oklahoma and Pennsylvania — join Indiana, Kentucky, Ohio, West Virginia and hard-hit Michigan. 

Novo asked the court to permanently stop Lilly from running the “deceptive” ads and require the drugmaker to issue corrective advertising.

The FDA’s investigation into the source of the cyclosporiasis outbreak is causing confusion as companies and consumers alike navigate new updates.

While some research has shown benefits for patients who qualify, questions remain about the therapy’s long-term risks and use among men without a medical need. 

The healthcare giant is working to stabilize margins by shrinking membership, exiting unprofitable contracts and pouring $1.5 billion into AI.

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk’s obesity injection Wegovy and diabetes counterpart Ozempic.

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.

Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.